Forskning
Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital
Udgivet

Long-term leukopenia in a lung transplanted patient with cystic fibrosis treated with zoledronic acid: a case report

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • A Karahasanovic
  • A-L Thorsteinsson
  • N H Bjarnason
  • P Eiken
Vis graf over relationer

Cystic fibrosis (CF) is a serious autosomal recessive genetic disorder associated with chronic lung disease, malabsorption, malnutrition, pancreatic insufficiency and premature respiratory failure. Recent advances in medical science and technology have increased the lifespan of patients with CF, albeit with long-term consequences of the disease, such as osteoporosis, becoming of increasing significance. The medical treatment of osteoporosis in patients with CF or after organ transplantation is still being explored, and no clear guidelines regarding the best choice of bisphosphonate exist. We report a case of a young woman with CF, lung transplantation and low bone mass developing long-term leukopenia after treatment with zoledronic acid. The leukopenia, with a strong affection of the neutrocytes, lasted for 4 months and the condition only went into remission after granulocyte-colony stimulating factor (G-CSF) treatment. It is important to be aware of symptomatic leukopenia in immunosuppressive patients after treatment with zoledronic acid.

OriginalsprogEngelsk
TidsskriftOsteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
Vol/bind27
Udgave nummer8
Sider (fra-til)2621-5
ISSN0937-941X
DOI
StatusUdgivet - 14 apr. 2016

ID: 46402511